Replies to post #326579 on Anavex Life Sciences Corp (AVXL)

[Investor2014]

Imo a prophylactic dosing scheme with preventative utility in AD or broader might be considered an inventive step over known treatment methods, incl. previous A2-73 disclosures, depending on what new novel information can be disclosed in claim 1.